Inclusion Criteria:~* At least 50 years of age and diagnosed with mild to moderate Alzheimer's disease or
healthy volunteers~* fluent in reading and speaking English~* AD patients must have a reliable study partner
who will be in frequent contact with the patient and comply with protocol requirements~* AD patients who have
received AChEIs or memantine for at least 4 months and on stable therapy for at least 2 months prior to
starting study drug~
